
PR Newswire
- 13-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of two o...
SHENYANG, China, Aug. 5, 2025 /PRNewswire/ -- A news report from CRI: "Peach bloss...
The new video series features conversations with global experts and future-of-work influencer...
TOKYO, Aug. 5, 2025 /PRNewswire/ -- Japan Preschool Exchange (JPE), a cultural exchange program, inv...
The ultra-portable projector boasts a 110° integrated gimbal, Google TV, and real-time focus for eff...
SHANGHAI, Aug. 5, 2025 /PRNewswire/ -- Envision Energy, a global leader in green technology, has ann...
DUBAI, UAE, Aug. 5, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exc...
Inveniam invests $20 million in MANTRA to advance institutional infrastructure for tokenized privat...
HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock ...
• Successful validation of payloaded anti-colibactin toxin phage using IMPA™ technology • Demonstr...
GROWING SALES TO US$7.8 BILLION, NET PROFIT INCREASED TO US$628 MILLION HONG KONG, Aug. 5, 2025 /PRN...
TAIPEI, Aug. 5, 2025 /PRNewswire/ -- WiAdvance Technology, an innovative cloud service provid...


ภาษาไทย
English